Study Results Abstracts From Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) At 2025 ASCO Genitourinary Cancers Symposium
CHENGDU, China, Feb. 13, 2025 /PRNewswire/ -- At the American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium 2025, to be held in San Francisco, USA, from Feb. 13-15, 2025, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd...
Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies
Southern Star sets itself apart in the CRO market through a unique combination of trust, operational advantages, deep industry expertise, and a strong commitment to local resources. SAN ANTONIO, Feb. 13, 2025 /PRNewswire/ -- Frost & Sullivan...
Mafengwo AI Intelligent Application Integrates with DeepSeek Model, Leading the Intelligent Transformation of the Tourism Industry
BEIJING, Feb. 13, 2025 /PRNewswire/ -- As DeepSeek's cutting-edge technology rapidly expands across industries, Mafengwo announced the integration of its self-developed AI application with the DeepSeek large language model. In the initial phase, the...
Love is in the Air: Agoda Unveils Most Romantic Valentine's Day Destinations in Asia
SINGAPORE, Feb. 13, 2025 /PRNewswire/ -- Love is in full bloom as digital travel platform Agoda reveals the top 5 most romantic domestic destinations in Asia for couples to celebrate Valentine's Day. Kuala Lumpur (Malaysia) leads the pack, followed...
A New Japanese Cultural Experience by Isetan Shinjuku
Experience Japanese Culture with All Five Senses at the "JAPAN SENSES" Campaign – A Limited-Time Event Showcasing works that embody a uniquely Japanese sensibility, we aim to highlight the charm of both traditional and contemporary culture. TOKYO,...
HD Korea Shipbuilding & Offshore Engineering Leads the Zero-Carbon Era with 'SMR-Powered Ship'
- Received Approval in Principle (AIP) from the American Bureau of Shipping (ABS) for nuclear-powered container ship - Unveiled model at U.S. New Nuclear for Maritime Summit - showcasing economic efficiency, performance, and safety - "Developing a...
Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC
HONG KONG, Feb. 13, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized, double-blind, multicenter clinical trial (COMPASSION-30/AK104-309)...
KALiNA Power and Crusoe Sign Framework Agreement for Joint Development of Multiple Co-Sited AI Data Centre Projects in Alberta
Framework for joint development of multiple Crusoe AI focused data centres co-sited with KALiNA's near-zero-emissions natural gas-fired power plants using carbon capture and sequestration (Power-CCS) Anticipates Crusoe to own and operate its AI Data...